Daily News Podcast

Antibody cleared amyloid plaques, slowed cognitive decline

Publish date: July 27, 2018

 

An experimental agent slowed cognitive decline and cleared Alzheimer’s plaques. Can meteorology predict migraines? Why closing a patent foramen ovale is the right approach to prevent recurring ischemic stroke. And claims that cannabis relieves noncancer pain go up in smoke.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

NIH launches HEAL Initiative to combat opioid crisis
MDedge Pediatrics
FDA approves Epidiolex for Lennox-Gastaut syndrome and Dravet syndrome
MDedge Pediatrics
Pediatric inpatient seizures treated quickly with new intervention
MDedge Pediatrics
Fentanyl analogs nearly double their overdose death toll
MDedge Pediatrics
Assessing adverse events tied to outpatient opioid use in children
MDedge Pediatrics
Spinal muscular atrophy added to newborn screening panel recommendations
MDedge Pediatrics
Is fibromyalgia one disorder – or two?
MDedge Pediatrics
Is fish oil’s heart benefit a fish tale?
MDedge Pediatrics
Pseudotumor cerebri pediatric rates are rising
MDedge Pediatrics
Blood pressure meds cut cognitive impairment risk
MDedge Pediatrics